Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Evolva restructures as part of sales drive
by Melody M. Bomgardner
September 4, 2017
| A version of this story appeared in
Volume 95, Issue 35
The Swiss industrial biotech firm Evolva will reduce its workforce to 100 employees, from 178, to focus on commercializing its fermentation-derived food ingredients and increasing sales. The company makes food and nutraceutical ingredients including resveratrol, stevia, and vanillin via fermentation with modified microbes. Evolva named a new CEO in July; three other executives will step down by the end of the year. Evolva will also consolidate research activities at its headquarters in Reinach.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter